Investigating the Inhibition of Diindolylmethane Derivatives on SARS-CoV-2 Main Protease

被引:0
|
作者
Li, Wenjin [1 ]
Chang, Xiaoyu [2 ]
Zhou, Hang [1 ]
Yu, Wenquan [1 ]
Wang, Ruiyong [1 ]
Chang, Junbiao [1 ]
机构
[1] Zhengzhou Univ, Coll Chem, Pingyuan Lab, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Coll Pharm, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
fluorescence; inhibitors; main protease; molecular docking; MEDIATED OXIDATIVE STRESS; SERUM-ALBUMIN; IN-SILICO; DOCKING; FLUORESCENCE; INDOLE-3-CARBINOL; CORONAVIRUS; MECHANISM; BISINDOLE; APOPTOSIS;
D O I
10.1002/jmr.3101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The SARS-CoV-2 main protease (Mpro) is an essential enzyme that promotes viral transcription and replication. Mpro conserved nature in different variants and its nonoverlapping nature with human proteases make it an attractive target for therapeutic intervention against SARS-CoV-2. In this work, the interaction mechanism between Mpro and diindolylmethane derivatives was investigated by molecular docking, enzymatic inhibition assay, UV-vis, fluorescence spectroscopy, and circular dichroism spectroscopy. Results of IC50 values show that 1p (9.87 mu M) was the strongest inhibitor for Mpro in this work, which significantly inhibited the activity of Mpro. The binding constant (4.07 x 10(5) Lmol(-1)), the quenching constant (5.41 x 10(5) Lmol(-1)), and thermodynamic parameters indicated that the quenching mode of 1p was static quenching, and the main driving forces between 1p and Mpro are hydrogen bond and van der Waals force. The influence of molecular structure on the binding is investigated. Chlorine atoms and methoxy groups are favorable for the diindolylmethane derivative inhibitors of Mpro. This work confirms the changes in the microenvironment of Mpro by 1p, and provides clues for the design of potential inhibitors.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
    Kangsa Amporndanai
    Xiaoli Meng
    Weijuan Shang
    Zhenmig Jin
    Michael Rogers
    Yao Zhao
    Zihe Rao
    Zhi-Jie Liu
    Haitao Yang
    Leike Zhang
    Paul M. O’Neill
    S. Samar Hasnain
    Nature Communications, 12
  • [2] Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
    Amporndanai, Kangsa
    Meng, Xiaoli
    Shang, Weijuan
    Jin, Zhenmig
    Zhao, Yao
    Rao, Zihe
    Liu, Zhi-Jie
    Yang, Haitao
    Zhang, Leike
    O'Neill, Paul M.
    Hasnain, S. Samar
    Rogers, Michael
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
    Katagishi, Daiki
    Yasuda, Daisuke
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    Ohe, Tomoyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [4] Inhibition of the SARS-CoV-2 main protease by a thiadiazolidinone derivative
    Jovic, Katarina
    Brown, Logan
    Vashisth, Harish
    Varga, Krisztina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 340A - 340A
  • [5] Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
    Wang, Qian
    Song, Yuanyuan
    Kim, Mungu
    Hahn, Sei Kwang
    Jiang, Ge
    BIOMATERIALS RESEARCH, 2023, 27 (01)
  • [6] Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
    Qian Wang
    Yuanyuan Song
    Mungu Kim
    Sei Kwang Hahn
    Ge Jiang
    Biomaterials Research, 27
  • [7] Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
    Nemukhin, A. V.
    Grigorenko, B. L.
    Lushchekina, S. V.
    Varfolomeev, S. D.
    RUSSIAN CHEMICAL BULLETIN, 2021, 70 (11) : 2084 - 2089
  • [8] Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
    A. V. Nemukhin
    B. L. Grigorenko
    S. V. Lushchekina
    S. D. Varfolomeev
    Russian Chemical Bulletin, 2021, 70 : 2084 - 2089
  • [9] SARS-CoV-2 Main Protease as Target
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1278 - 1278
  • [10] Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
    Ye, Naike
    Caruso, Francesco
    Rossi, Miriam
    BIOPHYSICA, 2021, 1 (04): : 377 - 404